BayerCropScience, Cellectis Extend Plant Genome Editing Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Bayer CropScience said today it has inked two agreements with Cellectis plant sciences that extend a partnership focused on modifying and editing plant genes and genomes to improve crops.

Under the agreements, the partners will use tools Cellectis developed to create commercial traits for the canola seed market, and Bayer will have access to Cellectis' technologies for gene stacking and targeted mutagenesis that enable it to engineer plant genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.